Breaking News Instant updates and real-time market news.

CI

Cigna

$158.99

0.78 (0.49%)

, ESRX

Express Scripts

$0.00

(0.00%)

09:07
04/04/19
04/04
09:07
04/04/19
09:07

Cigna, Express Scripts launch two voice skills for Amazon Alexa

Cigna (CI) and Express Scripts (ESRX) have collaborated with Amazon (AMZN) Alexa to launch two voice skills to make health care more engaging, personalized and convenient for customers. The Cigna and Express Scripts Alexa skills will enable eligible customers to use voice technology to manage pharmacy prescriptions, engage in health improvement programs and track wellness incentives. The Express Scripts voice skill is available now to customers who use Express Scripts' prescription home delivery services. Users can say, "Alexa, open Express Scripts" to check their prescription order status and set notifications for when orders are received, processed and shipped. Cigna is piloting "Cigna Health Today," a voice skill aimed at increasing proactive health engagement with one of Cigna's national clients. Eligible employees can opt-in to track personalized wellness incentives, including redeemable gift dollars, which are used to reward healthy behaviors. They can also receive daily motivational health and well-being tips.

CI

Cigna

$158.99

0.78 (0.49%)

ESRX

Express Scripts

$0.00

(0.00%)

AMZN

Amazon.com

$1,821.00

8.27 (0.46%)

  • 04

    Apr

  • 24

    Apr

  • 02

    May

  • 23

    Jun

CI Cigna
$158.99

0.78 (0.49%)

03/29/19
03/29/19
DOWNGRADE

WellCare downgraded to Hold at Argus on Centene merger
Argus analyst David Toung downgraded WellCare (WCG) to Hold after it agreed to be acquired by Centene (CNC) in a $17.3B deal or at $305.39 per share. The analyst notes that because the deal would yield an entity that is smaller than the insurance industry giants, it may receive a more favorable treatment from the regulators than the failed Aetna (AET) -Humana (HUM) and Anthem (ANTM)-Cigna (CI) deals, but warns that some antitrust scrutiny is still possible due to overlaps between the companies in a few states. Toung adds that the new company would have "strengths in Medicare Advantage and Medicaid, both of which are growing markets."
02/19/19
SBSH
02/19/19
NO CHANGE
SBSH
Buy
Citi confident in Cigna earnings target after CEO meetings
After hosting investor meetings with CEO David Cordani, Citi analyst Ralph Giacobbe has confidence in Cigna's $20-$21 earnings per share target for 2021. The analyst continues to view Cigna as a "compelling story and stock." The company is his top pick and highest conviction name. He keeps a Buy rating on the name.
03/05/19
MSCO
03/05/19
NO CHANGE
MSCO
Uncertain future of PBMs creating cloud over MCO group, says Morgan Stanley
Morgan Stanley analyst Zack Sopcak noted that managed care stocks he covers are down an average of 10% since February 22 and "theories abound" as to why. In talks with investors, he has heard Medicare for All, drug pricing hearings and cuts to insulin prices all mentioned as potential reasons for the pressure, though "none have really stuck," Sopcak stated. However, he does believe a lack of understanding or agreement on the future of PBMs and contributions to earnings in light of HHS' proposals have "created a cloud" over the MCO group, Sopcak said. The analyst, who calls out the magnitude of the move in UnitedHealth (UNH) in particular as unwarranted, points to three potential upcoming catalysts that can "break the group's malaise" prior to earnings: Anthem's (ANTM) investor day on March 7, Humana's (HUM) investor day on March 19 and the Medicare Advantage final rate setting announcement on April 1. Other MCOs include Cigna (CI), Centene (CNC), Molina Healthcare (MOH) and WellCare (WCG).
03/21/19
RAJA
03/21/19
UPGRADE
Target $8
RAJA
Outperform
Raymond James upgrades Diplomat Pharmacy, sees number of potential suitors
Raymond James analyst John Ransom upgraded Diplomat Pharmacy (DPLO) to Outperform from Market Perform with an $8 price target. The stock closed yesterday up 14c to $5.86. Following the 56% share decline since the February earnings delay, Diplomat would represent value to a strategic buyer, Ransom tells investor in a research note. The analyst sees a number of potential buyers that would "covet" Diplomat Pharmacy's infusion franchise and could fold its large mail order business into an existing platform, including UnitedHealth (UNH), Cigna (CI), CVS Health (CVS), Anthem (ANTM) and Centene (CNC). Ransom thinks Diplomat's current fundamentals should motivate its board to step up its assessment of strategic options. He believes the company's collection of assets are underappreciated at current valuation levels.
ESRX Express Scripts
$0.00

(0.00%)

12/20/18
JPMS
12/20/18
NO CHANGE
JPMS
Overweight
JPMorgan calls Cigna top idea to own into its Healthcare Conference
JPMorgan analyst Gary Taylor says Cigna (CI) is his top short-term idea to own into the 2019 JPMorgan Healthcare Conference. The analyst anticipates Cigna at the conference will be prepared to provide "at least high-level combined-company proforma 2019 guidance." He sees a "valuation catalyst" in the closing of the Express Scripts (ESRX) deal and keeps an Overweight rating on Cigna with a $250 price target.
12/18/18
RBCM
12/18/18
NO CHANGE
Target $34
RBCM
Outperform
AMD addition to Nasdaq-100 a 'small near-term positive', says RBC Capital
RBC Capital analyst Mitch Steves notes the addition of AMD (AMD) to the Nasdaq-100 index announced late on Friday, which also contained the inclusion of lululemon (LULU), NetApp (NTAP), United Continental Holdings (UAL), VeriSign (VRSN) and Willis Towers Watson (WLTW) and the subtraction of Express Scripts Holding (ESRX), Hologic (HOLX), Qurate Retail (QRTEA), Shire (SHPG), Seagate Technology (STX) and Vodafone Plc (VOD). The analyst believes that the change - which will become effective before the market open on December 24th - could act as a "small near-term positive" for AMD shares, even though it does not change its fundamentals. Longer term, the analyst keeps his Outperform rating and $34 price target on AMD, but warns that the company is faced with a crypto currency downdraft in the Gaming segment and that he is also cautious on the hyperscale spending trends next year which he estimates in the low single digits. Steves adds that the notable investor debate is also taking place around the AMD server average selling prices, which he sees coming in around $5,400 - the higher end of the more bullish forecasts of $5K-$6K vs. the bears' estimate around $4K.
01/03/19
WELS
01/03/19
NO CHANGE
Target $200
WELS
Market Perform
Cigna price target lowered to $200 from $221 at Wells Fargo
Wells Fargo analyst Peter Costa believes Anthem (ANTM) and Cigna (CI) may be spending much time in court fighting each other in 2019 and sees more risk for the latter than Anthem, since even if Cigna wins the first case it would have risk of losing the second where the sought damages against it are greater. Hence, it is possible that Cigna could agree to settle both cases for limited gains, he contends. Given the timing and Cigna's weakened balance sheet post the Express Scripts (ESRX) merger and plans to use Express Scripts' cash flow to reduce debt, Costa lowered his price target for Cigna to $200 from $221 and reiterated a Market Perform rating on the shares.
01/16/19
MSCO
01/16/19
NO CHANGE
MSCO
Morgan Stanley says UnitedHealth, Walgreens could benefit from CVS-Walmart fight
After CVS Health (CVS) announced Walmart (WMT) will leave Caremark's commercial and Managed Medicaid retail pharmacy networks at the end of April 2019, analysts at Morgan Stanley discussed the potential impact of the fight to both companies and to competitors. Analyst Ricky Goldwasser said the dispute "brings back memories" of the Express Scripts (ESRX) and Walgreens (WBA) breakup in 2011, but unlike in that case it is only the early days of the 2019/2020 selling season, not after the selling season concluded. Walmart's plans to leave should have a limited impact on CVS' FY19 EPS power, but adds uncertainty to PBM selling season if not resolved in the near-term, said Goldwasser. Morgan Stanley's Simeon Gutman said that if the dispute is not resolved, it could end up reducing Walmart's EBIT by about $260M in 2019, which he estimates could have a 7c, or 1.5%, impact on EPS. In terms of who may benefit if no resolution is reached, the team estimates both Walgreens and CVS retail could gain an incremental 25 bps of pharmacy share and that UnitedHealth's (UNH) Optum and Cigna (CI) could see a step up in PBM selling season win rates. However, given Walmart's relatively low share, they view the PBM share opportunity as "minimal."
AMZN Amazon.com
$1,821.00

8.27 (0.46%)

04/04/19
GUGG
04/04/19
DOWNGRADE
Target $72
GUGG
Neutral
Guggenheim downgrades Roku on increasing competition from Apple, Amazon
Guggenheim analyst Michael Morris downgraded Roku (ROKU) to Neutral from Buy and lowered his price target for the shares to $72 from $77. The stock closed yesterday down 3%, or $2.04, to $68.60. Morris this morning also upgraded Facebook (FB) to Buy from Neutral with a $200 price target. Apple's (AAPL) video product unveiled on March 25 represents an additional risk to Roku's active user base, the analyst tells investors in a research note. Further, Amazon's (AMZN) and Viacom's (VIAB) greater pushes into advertising video on demand are also increasing competition on Roku, Morris contends. He adds that Roku CFO Steve Louden's sale of 100,000 shares has also "shaken" his confidence in the stock. Nonetheless, the analyst's view of the "strong" secular streaming and targeted video advertising tailwinds that the company is positioned to benefit from is unchanged.
04/03/19
JEFF
04/03/19
NO CHANGE
Target $2300
JEFF
Buy
Jefferies analysis suggests Amazon shares can hit $3,000 in two years
Jefferies analyst Brent Thill continues to see 27% near-term upside from current levels for shares of Amazon.com but longer-term, he sees a roadmap to a $3,000-plus stock price. The analyst keeps a Buy rating on Amazon with a $2,300 price target. The stock closed yesterday at $1,813.98. Despite rallying 21% year-to-date, the shares remain "deeply undervalued," Thill tells investors in a research note. The analyst believes many any of Amazon's embedded growth opportunities are underappreciated "and the optionality from new initiatives is not reflected in the stock." His updated sum-of-the-parts analysis, based on estimate 2022 revenue, suggests ~65% upside to potential value of $3,000 in two years. The analysis is based on "relatively conservative" assumptions, particularly about growth in Amazon's most profitable segments - Web Services, advertising, and third party seller services. Thill believes Amazon has "just scratched the surface" in many of its existing markets.
04/02/19
JPMS
04/02/19
NO CHANGE
Target $435
JPMS
Overweight
Netflix recent underperformance brings good buying opportunity, says JPMorgan
Netflix (NFLX) shares are up 4% since its Q4 earnings report but are still underperforming the S&P 500 Index's 9% rally and average Internet peer gain of 8% despite the "strong" results, JPMorgan analyst Doug Anmuth tells investors in a research note. The analyst believes Netflix shares have been weighed down by uncertainty around the U.S./Latin America price increase impact on churn net additions in the first half of 2019, as well as the overhang from competitor launches out of Disney (DIS) and Apple (AAPL). However, the recent Netflix share price underperformance represents a good buying opportunity, Anmuth contends. He notes that he recently added the stock as one of his top picks along with Facebook (FB), Amazon.com (AMZN) and Twitter (TWTR). Anmuth believes the underlying secular shift toward on-demand entertainment "remains strong" and that competitive fears around Netflix are overdone. The company is on track to have 200M-plus global paid subscribers in 2021 and its U.S. revenue growth should accelerate from Q1 levels through 2019, contends the analyst. He reiterates an overweight rating on Netflix with a $435 price target, which represents 19% upside from current levels. The streaming service closed yesterday up $10.40, or 3%, to $366.96.
04/02/19
IMPC
04/02/19
NO CHANGE
Target $79
IMPC
Outperform
Atlas Air shares attractive after new Amazon agreement, says Imperial Capital
Atlas Air Worldwide (AAWW) shares are attractive considering the company's new agreement with Amazon.com (AMZN), "healthy" underlying revenue and earnings growth, and low valuations, Imperial Capital analyst Michael Derchin tells investors in a research note. He sees an attractive risk/reward opportunity and keeps an Outperform rating on Atlas Air with a $79 price target.

TODAY'S FREE FLY STORIES

LPL

LG Display

$8.35

-1.14 (-12.02%)

12:10
04/24/19
04/24
12:10
04/24/19
12:10
Downgrade
LG Display rating change  »

LG Display downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OXY

Occidental Petroleum

$60.91

-1.44 (-2.31%)

, APC

Anadarko

$71.89

7.77 (12.12%)

12:09
04/24/19
04/24
12:09
04/24/19
12:09
On The Fly
Fly Intel: Wall Street's top stories at midday »

The major averages are…

OXY

Occidental Petroleum

$60.91

-1.44 (-2.31%)

APC

Anadarko

$71.89

7.77 (12.12%)

CVX

Chevron

$118.80

-3.2 (-2.62%)

BA

Boeing

$378.71

4.67 (1.25%)

T

AT&T

$30.75

-1.36 (-4.24%)

CAT

Caterpillar

$138.18

-3.9 (-2.74%)

CBS

CBS

$51.44

0.09 (0.18%)

VIA

Viacom

$36.81

0.53 (1.46%)

VIAB

Viacom

$29.88

0.61 (2.08%)

SAP

SAP

$127.96

13.12 (11.42%)

SLAB

Silicon Labs

$105.83

12.195 (13.02%)

EBAY

eBay

$38.25

1.59 (4.34%)

RES

RPC, Inc.

$11.10

-1.8 (-13.95%)

IRBT

iRobot

$103.20

-27.22 (-20.87%)

SNAP

Snap

$11.36

-0.63 (-5.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 26

    Apr

  • 26

    Apr

  • 29

    Apr

  • 30

    Apr

  • 02

    May

  • 06

    May

  • 07

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 10

    May

  • 10

    May

  • 10

    May

  • 14

    May

  • 14

    May

  • 18

    May

  • 20

    May

  • 22

    May

  • 22

    May

  • 29

    May

  • 05

    Jun

  • 06

    Jun

  • 12

    Jun

  • 24

    Jul

  • 13

    Nov

TDOC

Teladoc

$54.67

0.32 (0.59%)

, HUM

Humana

$249.01

0.71 (0.29%)

12:09
04/24/19
04/24
12:09
04/24/19
12:09
Recommendations
Teladoc, Humana analyst commentary at Baird »

Humana virtual primary…

TDOC

Teladoc

$54.67

0.32 (0.59%)

HUM

Humana

$249.01

0.71 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 01

    May

  • 22

    May

  • 23

    May

  • 05

    Jun

  • 13

    Nov

MPC

Marathon Petroleum

$60.06

-0.94 (-1.54%)

12:05
04/24/19
04/24
12:05
04/24/19
12:05
Options
Marathon Petroleum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 08

    May

UMC

UMC

$1.94

0.015 (0.78%)

12:04
04/24/19
04/24
12:04
04/24/19
12:04
Upgrade
UMC rating change  »

UMC upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

LRN

K12

$31.56

-4.665 (-12.88%)

12:01
04/24/19
04/24
12:01
04/24/19
12:01
Hot Stocks
K12 falls -12.4% »

K12 is down -12.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPN

Superior Energy

$4.28

-0.685 (-13.80%)

12:01
04/24/19
04/24
12:01
04/24/19
12:01
Hot Stocks
Superior Energy falls -13.9% »

Superior Energy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

RES

RPC, Inc.

$11.04

-1.86 (-14.42%)

12:01
04/24/19
04/24
12:01
04/24/19
12:01
Hot Stocks
RPC, Inc. falls -14.2% »

RPC, Inc. is down -14.2%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 08

    May

  • 09

    May

  • 13

    Nov

SAP

SAP

$128.22

13.38 (11.65%)

12:01
04/24/19
04/24
12:01
04/24/19
12:01
Hot Stocks
SAP rises 11.7% »

SAP is up 11.7%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 07

    May

APC

Anadarko

$71.92

7.8 (12.16%)

12:00
04/24/19
04/24
12:00
04/24/19
12:00
Hot Stocks
Anadarko rises 12.4% »

Anadarko is up 12.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

  • 22

    May

TRK

Speedway Motorsports

$18.50

4.52 (32.33%)

12:00
04/24/19
04/24
12:00
04/24/19
12:00
Hot Stocks
Speedway Motorsports rises 32.8% »

Speedway Motorsports is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

12:00
04/24/19
04/24
12:00
04/24/19
12:00
General news
Treasury Action: Fed funds futures are rallying alongside the surge in Treasuries »

Treasury Action: Fed…

HMST

HomeStreet

$28.08

(0.00%)

11:50
04/24/19
04/24
11:50
04/24/19
11:50
Hot Stocks
HomeStreet 'disappointed' over Blue Lion's director nominations, proposals »

HomeStreet issued a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

PYPL

PayPal

$107.92

1.01 (0.94%)

, FB

Facebook

$183.84

0.07 (0.04%)

11:50
04/24/19
04/24
11:50
04/24/19
11:50
Earnings
Fly Intel: What to watch in PayPal earnings report »

PayPal (PYPL) is…

PYPL

PayPal

$107.92

1.01 (0.94%)

FB

Facebook

$183.84

0.07 (0.04%)

EBAY

eBay

$38.45

1.79 (4.88%)

JPM

JPMorgan

$113.45

-0.29 (-0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 09

    May

  • 14

    May

  • 21

    May

  • 22

    May

  • 29

    May

  • 30

    May

  • 03

    Jun

  • 11

    Jun

  • 16

    Jul

AMRN

Amarin

$18.32

-0.07 (-0.38%)

11:45
04/24/19
04/24
11:45
04/24/19
11:45
Options
Amarin call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 01

    May

  • 06

    May

11:45
04/24/19
04/24
11:45
04/24/19
11:45
General news
Treasury's $20 B FRN auction was awarded at a high discount margin of 0.139% »

Treasury's $20 B FRN…

LRN

K12

$31.11

-5.115 (-14.12%)

11:40
04/24/19
04/24
11:40
04/24/19
11:40
Recommendations
K12 analyst commentary at Barrington »

Barrington reiterates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$262.87

-0.98 (-0.37%)

, SSNLF

Samsung

$0.00

(0.00%)

11:40
04/24/19
04/24
11:40
04/24/19
11:40
Earnings
Fly Intel: What to watch in Tesla earnings report »

Tesla (TSLA) is scheduled…

TSLA

Tesla

$262.87

-0.98 (-0.37%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

CAT

Caterpillar

$138.82

-3.26 (-2.29%)

11:37
04/24/19
04/24
11:37
04/24/19
11:37
Hot Stocks
Breaking Hot Stocks news story on Caterpillar »

Caterpillar: Trade…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 12

    Jun

GWW

Grainger

$292.75

-0.46 (-0.16%)

11:37
04/24/19
04/24
11:37
04/24/19
11:37
Hot Stocks
Grainger authorizes repurchase of additional 5M shares »

W.W. Grainger announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

BKU

BankUnited

$35.97

0.24 (0.67%)

11:36
04/24/19
04/24
11:36
04/24/19
11:36
Downgrade
BankUnited rating change at Sandler ONeill »

BankUnited downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 15

    May

GWW

Grainger

$292.73

-0.48 (-0.16%)

11:36
04/24/19
04/24
11:36
04/24/19
11:36
Hot Stocks
Grainger raises dividend by 6% to $1.44 per share »

W.W. Grainger announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

BBY

Best Buy

$75.08

1.48 (2.01%)

, PG

Procter & Gamble

$104.47

1.28 (1.24%)

11:36
04/24/19
04/24
11:36
04/24/19
11:36
On The Fly
Best Buy, P&G, Snap upgrades among today's top analyst calls »

Check out today's top…

BBY

Best Buy

$75.08

1.48 (2.01%)

PG

Procter & Gamble

$104.47

1.28 (1.24%)

SNAP

Snap

$11.20

-0.79 (-6.59%)

KHC

Kraft Heinz

$32.73

-0.365 (-1.10%)

AAPL

Apple

$208.23

0.73 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 23

    May

  • 29

    May

  • 03

    Jun

TEVA

Teva

$14.98

0.07 (0.47%)

, MYL

Mylan

$26.47

-0.13 (-0.49%)

11:35
04/24/19
04/24
11:35
04/24/19
11:35
Recommendations
Teva, Mylan, Novartis analyst commentary at Wells Fargo »

Sandoz results should not…

TEVA

Teva

$14.98

0.07 (0.47%)

MYL

Mylan

$26.47

-0.13 (-0.49%)

NVS

Novartis

$78.35

2.51 (3.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 28

    Apr

  • 02

    May

  • 03

    May

  • 04

    May

  • 08

    May

  • 22

    May

  • 31

    May

YPF

YPF

$14.54

-0.35 (-2.35%)

11:35
04/24/19
04/24
11:35
04/24/19
11:35
Options
YPF put volume heavy and directionally bearish »

Bearish flow noted in YPF…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.